Terumo Co. (OTCMKTS:TRUMY) Sees Significant Decline in Short Interest

Terumo Co. (OTCMKTS:TRUMY) saw a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 700 shares, a decline of 76.7% from the February 29th total of 3,000 shares. Based on an average daily trading volume, of 27,800 shares, the short-interest ratio is currently 0.0 days.

Terumo Stock Up 1.2 %

Shares of OTCMKTS TRUMY opened at $37.36 on Thursday. Terumo has a 52-week low of $25.11 and a 52-week high of $41.19. The firm has a market capitalization of $27.93 billion, a price-to-earnings ratio of 38.84 and a beta of 0.65. The stock has a 50 day moving average price of $36.72 and a 200 day moving average price of $32.26. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.13 and a current ratio of 1.90.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $0.27 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.27. Terumo had a return on equity of 8.26% and a net margin of 11.14%. The business had revenue of $1.62 billion for the quarter. Sell-side analysts expect that Terumo will post 1.14 earnings per share for the current year.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.